Logo

Nuvelo Takes in $74.8M in Gross Proceeds from Common Stock Offering

Mar 09, 2004

NEW YORK, March 9 (GenomeWeb News) - Nuvelo has completed its common stock offering, resulting in approximately $74.8 million in gross proceeds, the company said yesterday.

 

Nuvelo sold 5.75 million shares in total, including 5 million shares from its public offering and 750,000 shares offered to underwriters as an option.

 

UBS Securities was the sole book-running manager in the offering, while CIBC World Markets, Needham & Company, and JMP Securities were co-managers.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.